Long-acting beta-adrenoceptor agonists

DBCAT003884Pharmacologic class

Inhaled medications that are used in the treatment of asthma and chronic obstuctive pulmonary disease (COPD). A DrugBank category of 9 drugs. 8 of them are approved.

Part of: Agents to Treat Airway Disease
Also known as: LABAs · Long acting beta agonists (LABA) · Long-Acting Beta Agonist · long-acting beta-2 adrenergic agonist · long-acting beta-2 adrenoceptor agonist
Drugs: Arformoterol
Bambuterol
Clenbuterol
Formoterol
Indacaterol
Olodaterol
Protokylol
Salmeterol
Vilanterol

What you can answer from here — as of May 20, 2021

9DrugsEach linked to its full drug card

Listed above

7Drug targetsEvery drug–target pair in the class, with bond type

2,205Marketed productsAcross the regions we cover, with dosage forms and routes

4Routes of administrationHow the drugs in this class are given

Which targets do Long-acting beta-adrenoceptor agonists share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account